Business
Aelis Farma: Combined General Meeting of May 27, 2025: Availability of Preparatory Documents and Participation and Voting Procedures
BORDEAUX, France, May 06, 2025--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and peripheral diseases involving the CB1 receptor, informs its shareholders and the financial community that the Company’s Combined General Meeting will be held on Tuesday, May 27, 2025, at 2 p.m., at 1 rue Lafaurie de Monbadon, 33000 Bordeaux.
About this update from Aelis Farma Sa
[{"type":"text","content":"BORDEAUX, France, May 06, 2025--(BUSINESS WIRE)--Regulatory News:","length":65,"tagName":"p"},{"type":"text","content":"Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and peripheral diseases involving the CB1 receptor, informs its shareholders and the financial community that the Company’s Combined General Meeting will be held on Tuesday, May 27, 2025, at 2 p.m., at 1 rue Lafaurie de Monbadon, 33000 Bordeaux.","length":394,"tagName":"p"},{"type":"text","content":"The notice of the meeting, including the agenda and draft resolutions as well as the terms and conditions of participation and voting at the meeting, was posted on the website of the Bulletin des Annonces Légales Obligatoires "BALO" on April 18, 2025 (bulletin number 47).","length":282,"tagName":"p"},{"type":"text","content":"Shareholders who are unable to attend the meeting in person, may exercise their voting rights remotely, before the general meeting:","length":131,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"either by sending a proxy to the Company,","length":41,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"or by voting by mail,","length":21,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":62,"olType":false},{"type":"text","content":"At this purpose, shareholders shall use the form available on www.aelisfarma.com in accordance with the procedures indicated in the notice of meeting published on April 18, 2025, in the BALO.","length":191,"tagName":"p"},{"type":"text","content":"All documents relating to this General Meeting are available on request from the Company or can be consulted on the Company's website under the heading Investors / General Meetings.","length":185,"tagName":"p"},{"type":"text","content":"In accordance with the applicable legal and regulatory provisions:","length":66,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"any registered shareholder may, up to and including the fifth day before the general meeting, request that the Company send him the documents provided for in Articles L. 225-115 and R. 225-83 of the Commercial Code. In the event of an express request, such documents may be sent by electronic means. For holders of bearer shares...